Dupilimab
Alternative Names: Dupixent
Dupixent (dupilumab) is a biologic medication used to treat eosinophilic esophagitis (EoE) by reducing the type of allergic inflammation that causes damage and narrowing of the esophagus. It works by blocking the IL-4 and IL-13 pathways, which are key drivers of eosinophilic inflammation. In clinical trials, many patients experienced improvement in swallowing difficulty, reduced food impactions, and decreased eosinophils in the esophagus. It is given as a weekly injection under the skin and is often considered for patients whose symptoms are not adequately controlled with diet changes, proton pump inhibitors, or swallowed steroids.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: Injection
Review Summary
Dupilumab (Dupixent) is a biologic injection given every 2 weeks that can significantly reduce inflammation and improve swallowing symptoms in many eosinophilic esophagitis patients, with many reporting improvement within 2-4 weeks. While it may work faster than some other treatments, the injection frequency is less convenient than pills or dietary options, though copay assistance programs can help with affordability despite potential insurance approval challenges.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Cost
Relief Speed
Side Effects
Treatment LineExplore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
4.0
AI Summary of User Experiences
Not medical advice.
Dupilumab (Dupixent) is a biologic injection given every 2 weeks that can significantly reduce inflammation and improve swallowing symptoms in many eosinophilic esophagitis patients, with many reporting improvement within 2-4 weeks. While it may work faster than some other treatments, the injection frequency is less convenient than pills or dietary options, though copay assistance programs can help with affordability despite potential insurance approval challenges.
Cost Relief Speed Side Effect Treatment Line
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
Reviews
Filter by reviewer type Pro